Amgen Inc. (AMGN) Stock

About Amgen Inc.

Amgen Inc. is led by CEO Robert A. Bradway, employs 28,000 people, headquartered in Thousand Oaks, US, publicly traded since 1983.

Amgen Inc. (AMGN) stock trades at $432.49 with a market capitalization of $233.82B. The stock is valued at a price-to-earnings (P/E) ratio of 25.56, price-to-book of 19.16, price-to-sales of 5.87. Over the past 52 weeks the stock has ranged between $269.77 and $447.03, and currently trades 3.3% below its 52-week high. It pays a dividend yielding 2.43%.

On profitability, Amgen Inc. generates a return on equity (ROE) of 89.32%, above the typical market range of roughly 12-15%, return on capital employed of 18.03%, an operating margin of 31.63%, a net profit margin of 22.93%.

In its most recent fiscal year, Amgen Inc. reported annual revenue of $36.7B, net profit of $7.7B. Over the last 5 fiscal years, revenue grew at an average annual rate of 7.6%, and net profit grew at an average annual rate of 1.2%.

The balance sheet shows a debt-to-equity ratio of 4.90 (debt more than twice shareholders' equity), a current ratio of 1.14, total assets of $90.6B, $9.1B in cash and equivalents.

AMGN has a beta of 0.43 (historically less volatile than the overall market).